在IBD中预测MASLD风险:开发了两个量身定制的临床评分
Remus Stafie1,2, Robert Nastasa1,2, Carol Stanciu2
1Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 在炎症性肠病 (IBD) 患者中很常见. 新的临床评分有助于识别有风险的个体,以便在IBD中早期检测MASLD.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 代谢疾病 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 在炎症性肠病 (IBD) 患者中越来越普遍.
- 目前的诊断工具缺乏IBD人群中MASLD的特异性,需要开发量身定制的预测模型.
- 识别风险因素对于早期检测和管理IBD患者的MASLD至关重要.
研究的目的:
- 在IBD患者中确定与MASLD相关的关键风险因素.
- 开发和验证IBD中MASLD的新型疾病特异性预测模型.
- 将新模型的表现与现有指数 (如HSI和FLI) 进行比较.
主要方法:
- 一项追溯前性队列研究,涉及157名IBD患者 (性结肠炎和克罗恩病).
- 进行了连续的临床,实验室和成像评估,通过过渡性弹性学 (CAP) 评估肝硬化症.
- 后勤回归分析确定了独立的风险因素,从而创建了添加和后勤回归的临床分数.
主要成果:
- 在23.5%的IBD患者中,MASLD被诊断为IBD.
- 独立预测因素包括吸烟,脂质不良,高血压,IBD持续时间较长,BMI较高,男性性别,频繁爆发和使用皮质类固醇.
- 与HSI和FLI相比,开发的临床评分显示出更高的性能,CAP是最准确的诊断工具.
结论:
- 在IBD患者中,MASLD非常普遍,受到代谢和IBD特定因素的影响.
- 拟议的临床评分为IBD早期MASLD风险分层提供了简单,易于使用的方法.
- 这些工具可以指导个性化的监控策略,特别是当先进的成像无法使用时.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
